EMEA-000689-PIP01-09-M09
Key facts
Invented name |
|
Active substance |
exenatide
|
Therapeutic area |
Endocrinology, -gynacology-fertility-metabolism
|
Decision number |
P/0017/2020
|
PIP number |
EMEA-000689-PIP01-09-M09
|
Pharmaceutical form(s) |
|
Condition(s) / indication(s) |
Treatment of type II diabetes mellitus
|
Route(s) of administration |
Subcutaneous use
|
Contact for public enquiries |
AstraZeneca AB
Tel. +46 8553 27591 |
Decision type |
PM: decision on the application for modification of an agreed PIP
|